A simple sensitive radioreceptor assay for calcium antagonist drugs

Robert J. Gould, Kenneth M M Murphy, Solomon H Snyder

Research output: Contribution to journalArticle

Abstract

A radioreceptor assay for calcium channel antagonist drugs described here is based on the ability of these drugs to affect 3H-nitrendipine binding to calcium channels. All the known calcium channel antagonists may be assayed in this manner. The assay can detect 10-100 nM (4 - 40 ng/ml) nimodipine, 10-100 nM (3.5 - 35 ng/ml) nifedipine, 3-30 μM (1.2 - 12 μm/ml) prenylamine, 0.1 - 1.0 μM (49 - 490 ng/ml) verapamil and 3-30 μM (1.2 - 12 μg/ml) diltiazem. These values cover the range of concentrations of calcium channel antagonists that are clinically important. As the radioreceptor assay detects active metabolites as well as the parent drugs, it should prove a useful adjunct in cardiovascular therapy. The method is more reproducible, simpler and less expensive than other methods such as high pressure liquid chromatography.

Original languageEnglish (US)
Pages (from-to)2665-2672
Number of pages8
JournalLife Sciences
Volume33
Issue number26
DOIs
StatePublished - Dec 26 1983

Fingerprint

Radioligand Assay
Calcium Channel Blockers
Assays
Calcium
Prenylamine
High pressure liquid chromatography
Pharmaceutical Preparations
Nitrendipine
Nimodipine
Diltiazem
Calcium Channels
Metabolites
Verapamil
High Pressure Liquid Chromatography
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

A simple sensitive radioreceptor assay for calcium antagonist drugs. / Gould, Robert J.; Murphy, Kenneth M M; Snyder, Solomon H.

In: Life Sciences, Vol. 33, No. 26, 26.12.1983, p. 2665-2672.

Research output: Contribution to journalArticle

Gould, Robert J. ; Murphy, Kenneth M M ; Snyder, Solomon H. / A simple sensitive radioreceptor assay for calcium antagonist drugs. In: Life Sciences. 1983 ; Vol. 33, No. 26. pp. 2665-2672.
@article{4eb8918b63be47158832cb88f66c82ec,
title = "A simple sensitive radioreceptor assay for calcium antagonist drugs",
abstract = "A radioreceptor assay for calcium channel antagonist drugs described here is based on the ability of these drugs to affect 3H-nitrendipine binding to calcium channels. All the known calcium channel antagonists may be assayed in this manner. The assay can detect 10-100 nM (4 - 40 ng/ml) nimodipine, 10-100 nM (3.5 - 35 ng/ml) nifedipine, 3-30 μM (1.2 - 12 μm/ml) prenylamine, 0.1 - 1.0 μM (49 - 490 ng/ml) verapamil and 3-30 μM (1.2 - 12 μg/ml) diltiazem. These values cover the range of concentrations of calcium channel antagonists that are clinically important. As the radioreceptor assay detects active metabolites as well as the parent drugs, it should prove a useful adjunct in cardiovascular therapy. The method is more reproducible, simpler and less expensive than other methods such as high pressure liquid chromatography.",
author = "Gould, {Robert J.} and Murphy, {Kenneth M M} and Snyder, {Solomon H}",
year = "1983",
month = "12",
day = "26",
doi = "10.1016/0024-3205(83)90351-X",
language = "English (US)",
volume = "33",
pages = "2665--2672",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "26",

}

TY - JOUR

T1 - A simple sensitive radioreceptor assay for calcium antagonist drugs

AU - Gould, Robert J.

AU - Murphy, Kenneth M M

AU - Snyder, Solomon H

PY - 1983/12/26

Y1 - 1983/12/26

N2 - A radioreceptor assay for calcium channel antagonist drugs described here is based on the ability of these drugs to affect 3H-nitrendipine binding to calcium channels. All the known calcium channel antagonists may be assayed in this manner. The assay can detect 10-100 nM (4 - 40 ng/ml) nimodipine, 10-100 nM (3.5 - 35 ng/ml) nifedipine, 3-30 μM (1.2 - 12 μm/ml) prenylamine, 0.1 - 1.0 μM (49 - 490 ng/ml) verapamil and 3-30 μM (1.2 - 12 μg/ml) diltiazem. These values cover the range of concentrations of calcium channel antagonists that are clinically important. As the radioreceptor assay detects active metabolites as well as the parent drugs, it should prove a useful adjunct in cardiovascular therapy. The method is more reproducible, simpler and less expensive than other methods such as high pressure liquid chromatography.

AB - A radioreceptor assay for calcium channel antagonist drugs described here is based on the ability of these drugs to affect 3H-nitrendipine binding to calcium channels. All the known calcium channel antagonists may be assayed in this manner. The assay can detect 10-100 nM (4 - 40 ng/ml) nimodipine, 10-100 nM (3.5 - 35 ng/ml) nifedipine, 3-30 μM (1.2 - 12 μm/ml) prenylamine, 0.1 - 1.0 μM (49 - 490 ng/ml) verapamil and 3-30 μM (1.2 - 12 μg/ml) diltiazem. These values cover the range of concentrations of calcium channel antagonists that are clinically important. As the radioreceptor assay detects active metabolites as well as the parent drugs, it should prove a useful adjunct in cardiovascular therapy. The method is more reproducible, simpler and less expensive than other methods such as high pressure liquid chromatography.

UR - http://www.scopus.com/inward/record.url?scp=0021024324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021024324&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(83)90351-X

DO - 10.1016/0024-3205(83)90351-X

M3 - Article

C2 - 6319847

AN - SCOPUS:0021024324

VL - 33

SP - 2665

EP - 2672

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 26

ER -